An investigation on behalf of investors in Masimo Corporation (NASDAQ:MASI) shares over potential wrongdoing at Masimo Corporation was announced.
San Diego, CA -- (SBWIRE) -- 11/09/2022 -- Certain directors of Masimo Corporation are under investigation concerning potential breaches of fiduciary duties.
Investors who purchased shares of Masimo Corporation (NASDAQ: MASI) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Masimo directors breached their fiduciary duties and caused damage to the company and its shareholders.
Irvine CA based Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide.
Masimo Corporation reported that its annual Total Revenue rose from over $1.14 billion in 2020 to over $1.23 billion in 2021, and that its Net Income declined from $240.3 million in 2020 to $229.64 million in 2021.
Shares of Masimo Corporation (NASDAQ: MASI) over $300 per share in late 2021 to as low as $121.33 per share on May 4, 2022.
Those who purchased shares of Masimo Corporation (NASDAQ: MASI) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.